No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Mizuho Securities Maintains GoodRx(GDRX.US) With Hold Rating
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
GoodRx Holdings: Navigating Leadership Transition and Legislative Uncertainty
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GoodRx Holdings: Buy Rating Reaffirmed Amid Leadership Stability and Growth Prospects